Creatine Supplementation and Diabetes

Diabetes Clinical Trial

Official title:

Efficacy and Safety of Creatine Supplementation Combined With Exercise Training in Type 2 Diabetic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00992043
• Other study ID #: eefeusp2
• Status: Completed
• Phase: N/A
• First received: October 7, 2009
• Last updated: March 22, 2010
• Start date: October 2009
• Est. completion date: January 2010

Study information

• Verified date: October 2009
• Source: University of Sao Paulo
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: National Committee of Ethics in Research
• Study type: Interventional

Clinical Trial Summary

Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The researchers aim to investigate whether this supplement can affect metabolic control in diabetic patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: January 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• males and females type 2 diabetic patients

• glycated hemoglobin between > 9%

• non insulin users

• physically inactive

• only metformin and/or sulfonylurea users

• BMI > 30 kg/m2

• age of years > 50 y

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Diabetes
• Renal Function

Intervention

Dietary Supplement:
• creatine

Other:
• Exercise training

Locations

Country	Name	City	State
Brazil	General Hospital - School of Medicine - University of Sao Paulo	Sao Paulo

Sponsors (1)

Lead Sponsor	Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	glycated hemoglobin		three months	No